Shroff Eric's Form 4 filing
Abbott LaboratoriesABT · filed Mar 3, 2026
- Accession no.
- 0002058129-26-000007
- Filed
- Mar 3, 2026
- Trade date
- Feb 27-Mar 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $81.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shroff EricCIK 0002058129 | Officer (Senior Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common shares without par value | FTax withholdingDisposed | −1,384 | $116.26 | −$160,903.84 | 39,873 | Direct | |
| Mar 2, 2026 | Common shares without par value | SSaleDisposed | −709 | $115.58 | −$81,946.22 | 39,164 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.